Provided are anti-HSV gD antibodies derived from a vaccinated human subject and rescued using recombinant DNA techniques. The antibodies specific for gD of HSV. Assay results are nearly equivalent for all amino acid substitutions except for the phenylalanine (F) at position 17 and the leucine (L) at position 22 that show dramatic reductions in binding. In addition, a slight reduction is seen for substitution at position 21 (aspartic acid, D).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-N0100-YC | Recombinant Human Anti-gD protein Antibody (CH-42) | ELISA, Neut | Human IgG |
HPAB-N0101-YC | Recombinant Human Anti-gD protein Antibody (CH-43) | ELISA, Neut | Human IgG |
There are currently no Customer reviews or questions for HPAB-N0101-YC-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.